A Mebendazole, analytical standard, >=98% (HPLC) CEP of the European Pharmacopoeia monograph is often referred to as a Mebendazole, analytical standard, >=98% (HPLC) Certificate of Suitability (COS). The purpose of a Mebendazole, analytical standard, >=98% (HPLC) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Mebendazole, analytical standard, >=98% (HPLC) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Mebendazole, analytical standard, >=98% (HPLC) to their clients by showing that a Mebendazole, analytical standard, >=98% (HPLC) CEP has been issued for it. The manufacturer submits a Mebendazole, analytical standard, >=98% (HPLC) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Mebendazole, analytical standard, >=98% (HPLC) CEP holder for the record. Additionally, the data presented in the Mebendazole, analytical standard, >=98% (HPLC) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Mebendazole, analytical standard, >=98% (HPLC) DMF.
A Mebendazole, analytical standard, >=98% (HPLC) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Mebendazole, analytical standard, >=98% (HPLC) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Mebendazole, analytical standard, >=98% (HPLC) suppliers with CEP (COS) on PharmaCompass.